Sedia Biosciences Receives WHO Pre-Qualification for its Asanté® HIV-1/2 Oral Fluid Test

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...
360Dx

Sedia Biosciences Gets WHO Prequalification Oral Fluid HIV-1/2 Test

Sedia's single-use, qualitative immunoassay, called the Asanté HIV-1/2 Oral Fluid Test, detects antibodies to HIV-1 and HIV-2 using oral fluids in as little as 20 minutes and is intended for use by ...
FierceBiotech

FDA approves Hologic's 2-in-1 HIV test for both diagnosis and viral load monitoring

Hologic has received a new FDA approval for its HIV test, allowing it to be used simultaneously to both diagnose infections and measure viral load. The company describes its Aptima HIV-1 Quant Dx ...
KOIN 6

MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use

HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today the approval from Health Canada for its Reveal®Rapid G4 HIV-1/2 Test (Reveal® ...
News Medical

The Evolution of HIV Diagnostic Testing

Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV) that attacks the body’s immune system, making it vulnerable to all infections. One of the major concerns ...